Protocolo terapéutico de las dislipemias aterogénicas

2000, Un instrumento de la prevención cardiovascular. Ministerio de Sanidad y Consumo. Sociedad Española de Cardiología y Sociedad Española de Arteriosclerosis, Clin Invest Arterioescler, 12, 125 Feher, 1995, Longterm safety of statinfibrate combination treatment in the management of hypercholesterolemia in patients with coronary heart disease, Br Heart J, 74, 14, 10.1136/hrt.74.1.14 Knopp, 1999, Drug treatment of lipid disorders, N Engl J Med, 341, 498, 10.1056/NEJM199908123410707 Illinworth, 1994, A review of clinical trials comparing HMG-CoA reductase inhibitors, Clin Ther, 16, 366 Pierce, 1990, Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination theraphy, JAMA, 264, 71, 10.1001/jama.1990.03450010075034